LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions.
LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 93 million patients in 130 countries. For over 30 years, LEO Pharma Canada has focused on improving the quality of patients’ lives.
DERMATOLOGY UPDATE SPONSOR LEO Pharma
Are you a dermatologist or a family physician?
Enjoy a complimentary e-subscription to SkinTherapyLetter®, a prestigious Dermatology journal indexed with the National Library in Washington.